448 related articles for article (PubMed ID: 19102960)
1. Lipid signal in evaluation of intracranial meningiomas.
Qi ZG; Li YX; Wang Y; Geng DY; Li KC; Shen TZ; Chen XR
Chin Med J (Engl); 2008 Dec; 121(23):2415-9. PubMed ID: 19102960
[TBL] [Abstract][Full Text] [Related]
2. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.
Demir MK; Iplikcioglu AC; Dincer A; Arslan M; Sav A
Eur J Radiol; 2006 Oct; 60(1):48-55. PubMed ID: 16844335
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
[TBL] [Abstract][Full Text] [Related]
4. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo HR-MAS MRS of human meningiomas: a comparison with in vivo 1H MR spectra.
Tugnoli V; Schenetti L; Mucci A; Parenti F; Cagnoli R; Righi V; Trinchero A; Nocetti L; Toraci C; Mavilla L; Trentini G; Zunarelli E; Tosi MR
Int J Mol Med; 2006 Nov; 18(5):859-69. PubMed ID: 17016616
[TBL] [Abstract][Full Text] [Related]
6. Intraventricular meningiomas: radiological findings and clinical features in 12 patients.
Kim EY; Kim ST; Kim HJ; Jeon P; Kim KH; Byun HS
Clin Imaging; 2009; 33(3):175-80. PubMed ID: 19411021
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of quantitative proton MR spectroscopy in the differentiation of benign and malignant meningioma.
Yue Q; Isobe T; Shibata Y; Kawamura H; Anno I; Matsumura A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Dec; 28(6):1103-9. PubMed ID: 22295694
[TBL] [Abstract][Full Text] [Related]
8. [Atypical and malignant intracranial meningiomas].
Gelabert-González M; Fernández-Villa JM; Iglesias-Pais M
Rev Neurol; 2004 Feb 16-29; 38(4):304-10. PubMed ID: 14997451
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging and diffusion-weighted images of cystic meningioma: correlating with histopathology.
Chen TY; Lai PH; Ho JT; Wang JS; Chen WL; Pan HB; Wu MT; Chen C; Liang HL; Yang CF
Clin Imaging; 2004; 28(1):10-9. PubMed ID: 14996441
[TBL] [Abstract][Full Text] [Related]
10. [Proton spectroscopy findings of meningioma].
Zhao JQ; Liang BL; Shen J; Tan XP; Zhang XH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):253-6. PubMed ID: 15807281
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
Devaprasath A; Chacko G
Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
[TBL] [Abstract][Full Text] [Related]
12. Microcystic meningioma: importance of obvious hypointensity on T1-weighted magnetic resonance images.
Chen CJ; Tseng YC; Hsu HL; Jung SM
J Comput Assist Tomogr; 2008; 32(1):130-4. PubMed ID: 18303301
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: is it possible to identify a clinically-aggressive subset of benign meningiomas?
Pfisterer WK; Hendricks WP; Scheck AC; Nieman RA; Birkner TH; Krampla WW; Preul MC
Neurosurgery; 2007 Nov; 61(5):1048-59; discussion 1060-1. PubMed ID: 18091281
[TBL] [Abstract][Full Text] [Related]
14. Is diffusion-weighted imaging useful in grading and differentiating histopathological subtypes of meningiomas?
Sanverdi SE; Ozgen B; Oguz KK; Mut M; Dolgun A; Soylemezoglu F; Cila A
Eur J Radiol; 2012 Sep; 81(9):2389-95. PubMed ID: 21723681
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.
Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M
Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215
[TBL] [Abstract][Full Text] [Related]
16. MRI findings of intracranial cystic meningiomas.
Zhang D; Hu LB; Zhen JW; Zou LG; Feng XY; Wang WX; Wen L
Clin Radiol; 2009 Aug; 64(8):792-800. PubMed ID: 19589418
[TBL] [Abstract][Full Text] [Related]
17. Correlating apparent diffusion coefficients with histopathologic findings on meningiomas.
Yin B; Liu L; Zhang BY; Li YX; Li Y; Geng DY
Eur J Radiol; 2012 Dec; 81(12):4050-6. PubMed ID: 22727725
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence.
Bollag RJ; Vender JR; Sharma S
Neuropathology; 2010 Jun; 30(3):279-87. PubMed ID: 19780983
[TBL] [Abstract][Full Text] [Related]
19. Metabolic alterations in the peritumoral brain in cases of meningiomas: 1H-MRS study.
Chernov MF; Nakaya K; Kasuya H; Kato K; Ono Y; Yoshida S; Nakamura R; Suzuki T; Muragaki Y; Iseki H; Kubo O; Hori T; Takakura K
J Neurol Sci; 2009 Sep; 284(1-2):168-74. PubMed ID: 19497588
[TBL] [Abstract][Full Text] [Related]
20. MRS study of meningeal hemangiopericytoma and edema: a comparison with meningothelial meningioma.
Righi V; Tugnoli V; Mucci A; Bacci A; Bonora S; Schenetti L
Oncol Rep; 2012 Oct; 28(4):1461-7. PubMed ID: 22824994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
